BHCM
LLY icon

Brevan Howard Capital Management’s Eli Lilly LLY Stock Holding History

Brevan Howard Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.5M Buy
77,094
+59,975
+350% +$61.3M 0.68% 26
2026
Q1 		$15.7M Sell
17,119
-1,443
-8% -$1.46M 0.14% 90
2025
Q4 		$20M Sell
18,562
-1,999
-10% -$1.91M 0.22% 71
2025
Q3 		$15.7M Buy
20,561
+385
+2% +$287K 0.07% 85
2025
Q2 		$15.7M Buy
20,176
+18,718
+1,284% +$14.5M 0.09% 112
2025
Q1 		$1.2M Sell
1,458
-21,977
-94% -$18.3M 0.01% 432
2024
Q4 		$18.1M Sell
23,435
-7,340
-24% -$6.08M 0.12% 38
2024
Q3 		$27.3M Buy
30,775
+30,213
+5,376% +$27.2M 0.19% 35
2024
Q2 		$509K Buy
+562
New +$450K ﹤0.01% 599
2024
Q1 		– Sell
-4,042
Closed -$2.36M – 1191
2023
Q4 		$2.36M Buy
+4,042
New +$2.36M 0.03% 104

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brevan Howard Capital Management's LLY Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Eli Lilly (LLY) stake by 350% in Q2 2026, buying an estimated $61.3M and bringing the position to 77,094 shares worth $92.5M. The position accounts for 0.68% of the portfolio, ranked #26.

Brevan Howard Capital Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brevan Howard Capital Management held 77,094 shares of Eli Lilly worth $92.5M as of Q2 2026.
  • Brevan Howard Capital Management bought 59,975 Eli Lilly shares in Q2 2026, an estimated $61.3M.
  • Eli Lilly made up 0.68% of Brevan Howard Capital Management's portfolio in Q2 2026, its #26 holding.
  • Brevan Howard Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.